← Back to NMTC

NeuroOne Medical Technologies Corporation - Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 13/08/2026Mar 2026Filed 13/08/2026Dec 2025Filed 13/08/2026Jun 2025Filed 13/08/2026Mar 2025Filed 13/08/2026Dec 2024Filed 13/08/2026Jun 2024Filed 14/08/2025Mar 2024Filed 14/08/2025
$2$1.9$2.9$1.7$1.4$3.3$0.8$1.4
−$2−$2.4−$1.4−$1.5−$2.3$1.8−$2.8−$2.9
−$0.28−$0.28−$0.03−$0.19−$0.44$0.06−$0.10−$0.11
8.78.5508.15.2312726

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.